Study of chilblains during COVID-19 infection
Part of Injuries & trauma clinical trials.
This study looks at skin lesions (chilblains) that appear in people with a confirmed COVID-19 infection. It aims to better understand these skin changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed COVID-19 infection (by a positive PCR test, antibody test, or lung CT scan).
- You must have had at least one skin lesion (like red or purple bumps, often on toes or fingers) that appeared during your COVID-19 infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at COVID-19 experiences in people who have a primary immune deficiency (a long-term immune problem) and who have had COVID-19. It may help researchers better understand how COVID-19 affects people with these conditions.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
This trial studies people who had COVID-19 to understand why some develop long-term symptoms while others recover fully. It aims to find links between the immune system and brain changes using imaging.
This study looks at how COVID-19 changes your genes, which might explain why some people have long-lasting symptoms. If you join, you'll provide a blood sample, and the results could help us better understand long COVID.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This study looks closely at how your immune system responds during COVID-19. It may help researchers better understand why COVID-19 varies from person to person and how to improve future care.
Hear when a new COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.